| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/17/2011 | EP2356130A1 Treatment of restless leg syndrome and sleep disorders |
| 08/17/2011 | EP2355838A2 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof |
| 08/17/2011 | EP2355831A1 Use of inkt or tlr agonists for protecting against or treating a disease such as acute infection or cancer |
| 08/17/2011 | EP2355830A1 Compositions comprising a calcium channel blocker or a calmodulin blocker for use in the removal of hyperplastic skin lesions |
| 08/17/2011 | EP2355829A1 Combination of insulin with triazine derivatives and its use for treating diabetes |
| 08/17/2011 | EP2355821A1 P70 s6 kinase inhibitor and egfr inhibitor combination therapy |
| 08/17/2011 | EP2355820A1 P70 s6 kinase inhibitor and mtor inhibitor combination therapy |
| 08/17/2011 | EP2355819A2 Treating cancer by modulating a mnk |
| 08/17/2011 | EP2355815A1 Use of leukotriene inhibitors for treating lung diseases in prematurely born infants |
| 08/17/2011 | EP2355814A2 Pyrones for the treatment of metabolic disorders |
| 08/17/2011 | EP2355811A2 Therapeutic compositions |
| 08/17/2011 | EP2355657A1 Compositions and methods of treating endothelial disorders |
| 08/17/2011 | EP1562571B1 Combination of a diamide derivative and immunosuppressive agents for inhibiting transplant rejection |
| 08/17/2011 | EP1558273B1 Treatment and prevention of pulmonary conditions |
| 08/17/2011 | EP1507558B1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 08/17/2011 | EP1485360B1 Sodium channel blockers |
| 08/17/2011 | EP1327003B1 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 08/17/2011 | CN1942197B Use of Lactic acid bacteria in preparing medicine for improved breast milk |
| 08/17/2011 | CN1829511B Use of telmisartan and amlodipine or Nifedipine in preparing medicine for increasing insulin sensitivity |
| 08/17/2011 | CN1822765B Delivery of compounds with rehydrated blood cells |
| 08/17/2011 | CN1637416B Labelled growth hormone secretagogue and its synthesis method and uses |
| 08/17/2011 | CN102159245A Combination of hcv ns3 protease inhibitor with interferon and ribavirin |
| 08/17/2011 | CN102159244A Intranasal compositions comprising decongestant and corticosteroid |
| 08/17/2011 | CN102154458A Method for identifying and treating Graves' disease and kit thereof |
| 08/17/2011 | CN102151335A Regulation of metabolism by protein lysine acetylation modification |
| 08/17/2011 | CN102151242A In-situ gel slow-release preparation for anti-tuberculosis drugs and preparation method thereof |
| 08/17/2011 | CN101511365B Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor |
| 08/17/2011 | CN101039696B Methods of healing wounds by administering human il-18 |
| 08/16/2011 | US7999073 Expression vector comprising nucleotide sequences coding nucleoprotein filaments for improving heterologous gene expression in cells |
| 08/16/2011 | US7999005 Growth stimulant compositions |
| 08/16/2011 | US7998953 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor |
| 08/16/2011 | US7998947 Moderation of intracellular signals; antitumor agents; drug screening; administering cucurbitacin compound |
| 08/16/2011 | US7998934 PAI-2 conjugates for the treatment and imaging of cancer |
| 08/16/2011 | US7998931 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/16/2011 | US7998502 Encapsulated vaccines for the oral vaccination and boostering of fish and other animals |
| 08/16/2011 | US7998492 Methods and products related to treatment and prevention of hepatitis C virus infection |
| 08/16/2011 | US7998478 Pharmaceutical composition for treating immune diseases |
| 08/16/2011 | US7998474 Methods for treating an inflammatory disease of the bowel |
| 08/16/2011 | US7998473 Methods of treatment or prevention of gastrointestinal disorders using canine probiotic bifidobacterium |
| 08/16/2011 | CA2493041C Injectable pharmaceutical composition for treating post-operative joint pain comprising an amide local anesthetic |
| 08/16/2011 | CA2468248C Pregnane steroids for use in the treatment of cns disorders |
| 08/16/2011 | CA2464770C Compound |
| 08/16/2011 | CA2456648C Human antibodies specific for interleukin 15 (il-15) |
| 08/16/2011 | CA2449002C Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin |
| 08/16/2011 | CA2405450C Dermacentor variabilis gaba-gated chloride channels |
| 08/16/2011 | CA2401624C Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant |
| 08/16/2011 | CA2400639C Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| 08/16/2011 | CA2389979C Methods of inhibiting metastasis |
| 08/16/2011 | CA2382941C Use of leptin in inhibition of endothelial cell proliferation |
| 08/16/2011 | CA2354325C Growth factor homolog zvegf3 |
| 08/16/2011 | CA2321837C Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 08/16/2011 | CA2174928C Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 08/11/2011 | WO2011097595A1 Methods of using agents that modulate claudin expression |
| 08/11/2011 | WO2011096438A1 Method and pharmaceutical composition for treatment of intestinal disease |
| 08/11/2011 | WO2011095585A1 Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof |
| 08/11/2011 | WO2011095553A1 Sgc stimulators or sgc activators in combination with pde5 inhbitors for the treatment of erectile dysfunction |
| 08/11/2011 | WO2011095534A1 sGC STIMULATORS OR sGC ACTIVATORS ALONE AND IN COMBINATION WITH PDE5 INHBITORS FOR THE TREATMENT OF CYSTIC FIBROSIS |
| 08/11/2011 | WO2011070358A3 Systemic administration of an agent that permeabilises tumour vasculature |
| 08/11/2011 | WO2011048479A3 Compositions that include anthocyanidins and methods of use |
| 08/11/2011 | WO2011002606A8 Methods of identifying a patient population eligible for treatment with nitric oxide via inhalation |
| 08/11/2011 | US20110196028 PCK ACTIVATION AS A MEANS FOR ENHANCING sAPPa SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS |
| 08/11/2011 | US20110195901 Artery- and vein-specific proteins and uses therefor |
| 08/11/2011 | US20110195456 Methods and compositions for the production of monoclonal antibodies |
| 08/11/2011 | US20110195063 Methods of Treating Ankylosing Spondylitis Using Anti-TNF Antibodies and Peptides of Human Tumor Necrosis Factor |
| 08/11/2011 | US20110195046 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 08/11/2011 | DE10347824B4 Pharmazeutische oder kosmetische Zusammensetzung zur Behandlung der Haut A pharmaceutical or cosmetic composition for treating the skin |
| 08/11/2011 | DE102010026879A1 Transdermal system, useful for indicating and preventing multiple sclerosis, immunomodulator including quinolines or isoxazoles, metabolite forming groups, skin protective layer, a reservoir and a carrier impermeable to active substance |
| 08/11/2011 | CA2788969A1 Sgc stimulators or sgc activators alone and in combination with pde5 inhbitors for the treatment of cystic fibrosis |
| 08/11/2011 | CA2788032A1 Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof |
| 08/10/2011 | EP2353592A1 Therapeutic causing contraction of mucosal tissue and method of treating diseases relating to mucosal tissues |
| 08/10/2011 | EP2353587A2 Antimicrobial compositions and methods |
| 08/10/2011 | EP2352722A2 Hydroxyadamantyl inhibitors of dipeptidylpeptidase iv |
| 08/10/2011 | EP2352510A1 Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta |
| 08/10/2011 | EP2352504A2 Treatment of proliferative disorders with a death receptor agonist |
| 08/10/2011 | EP2352499A1 Combination therapy comprising angiotensin receptor blockers and vasopressin receptor antagonists |
| 08/10/2011 | EP2352488A1 Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin |
| 08/10/2011 | EP2061513B1 Method of treating hepatitis c patients |
| 08/10/2011 | EP1609781B1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine |
| 08/10/2011 | EP1594513B1 Carbohydrate conjugates to prevent abuse of controlled substances |
| 08/10/2011 | EP1565581B1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 08/10/2011 | EP1507554B1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 08/10/2011 | EP1438388B1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 08/10/2011 | EP1411967B1 Blocking peptide for inflammatory cell secretion |
| 08/10/2011 | EP1383465B1 Acute pharmacologic augmentation of psychotherapy with d-cycloserine |
| 08/10/2011 | EP1341527B1 Pharmaceutical preparation comprising an active dispersed on a matrix |
| 08/10/2011 | EP1190074B1 Recombinant anti-cd40 antibody and uses thereof |
| 08/10/2011 | EP1135513B2 Adenovirus-mediated gene therapy |
| 08/10/2011 | CN1895672B Multifunctional broad-spectrum obtundent of polyphyletic synergistic and its use |
| 08/10/2011 | CN1741821B Compositions for cancer treatment |
| 08/10/2011 | CN102149407A Combination therapy for the treatment of diabetes and related conditions |
| 08/10/2011 | CN102145170A Sensitizer for radiotherapy and chemotherapy of malignant tumor |
| 08/10/2011 | CN102145169A Medicinal composition for eradicating helicobacter pylori and preparation method thereof |
| 08/10/2011 | CN102145168A Yoga meridian energy detoxification method and special essential oil |
| 08/10/2011 | CN102145163A Use of CNTF (ciliary neurotrophic factor) receptor activators for the treatment of obesity |
| 08/10/2011 | CN102145011A Composition for preventing and curing diarrhea, preparation method and application of composition |
| 08/10/2011 | CN101669925B Dry powder inhalation, preparation method and application thereof |
| 08/10/2011 | CN101394868B Strong immune induction by using combination of adenovirus type-5/type-35 vector and vaccinia virus mva vector |
| 08/10/2011 | CN101053447B Liquid compound for eliminating smoke harm and preparing method thereof |
| 08/10/2011 | CN101028516B Medicine preparation for oral cavity |
| 08/09/2011 | US7994294 Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |